Overview
Dr. Chellapandian is the division chief of blood and marrow transplant and specializes in bone marrow transplant as a hematologist-oncologist and serves as Director of the Center for Cell and Gene Therapy for Non-Malignant Conditions (CCGNC) in the Johns Hopkins All Children’s Cancer & Blood Disorders Institute. He joined the hospital staff in 2017. Dr. Chellapandian earned his medical degree from Madurai Medical College and then trained at Postgraduate Institute of Medical Education and Research, both in India. He completed a residency in pediatrics at Albert Einstein Medical Center in Philadelphia. Dr. Chellapandian completed a pediatric hematology-oncology and bone marrow transplantation fellowship at Hospital for Sick Children/University of Toronto and an advanced fellowship on bone marrow transplantation and cellular therapy at St. Jude Children’s Research Hospital in Memphis, Tennessee. Dr. Chellapandian's clinical and research interests include hematopoietic stem cell transplant for primary immunodeficiency, immune dysregulation disorders, sickle cell disease, thalassemia, and treatment of histiocytic disorders. He has special focus on ex-vivo graft engineering techniques and autologous gene therapy. He has adapted new methods of T- cell depletion using haploidentical transplantation to transplant patients lacking a suitable matched donor. He has numerous scientific papers and review articles published in this field.
Dr. Chellapandian is rated as an Experienced provider by MediFind in the treatment of Severe Combined Immunodeficiency (SCID). His top areas of expertise are Severe Combined Immunodeficiency (SCID), Non-Langerhans-Cell Histiocytosis, Infantile Neutropenia, Reticulohistiocytoma, and Bone Marrow Transplant.
His clinical research consists of co-authoring 10 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles and participated in 1 clinical trial in the study of Severe Combined Immunodeficiency (SCID).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- PPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- HMO
Locations
601 5th Street South, Suite 320, Suite 320, Saint Petersburg, FL 33701
Additional Areas of Focus
Dr. Chellapandian has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Aleksandra Petrovic is a Pediatric Hematologist Oncology provider in St Petersburg, Florida. Dr. Petrovic is rated as a Distinguished provider by MediFind in the treatment of Severe Combined Immunodeficiency (SCID). Her top areas of expertise are Severe Combined Immunodeficiency (SCID), X-Linked Severe Combined Immunodeficiency, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Vitrectomy.
Johns Hopkins All Children's Outpatient Care, St. Petersburg
Dr. Oshrine specializes in blood and marrow transplants as a pediatric hematologist/oncologist in the Johns Hopkins All Children’s Cancer & Blood Disorders Institute. His clinical focus is in the treatment of high-risk leukemias with blood and marrow transplantation, and his research focus is in immune recovery after transplant. He joined the hospital in 2014 after completing a fellowship in pediatric hematology/oncology at the Children’s Hospital of Philadelphia. He received the Excellence in Service & Professionalism Award in the 2018 Johns Hopkins Medicine Clinical Excellence Awards. Dr. Oshrine is rated as an Advanced provider by MediFind in the treatment of Severe Combined Immunodeficiency (SCID). His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Severe Combined Immunodeficiency (SCID), Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Gastrostomy.
Gauri Sunkersett is a Pediatric Hematologist Oncology provider in St Petersburg, Florida. Dr. Sunkersett is rated as an Experienced provider by MediFind in the treatment of Severe Combined Immunodeficiency (SCID). Her top areas of expertise are Severe Combined Immunodeficiency (SCID), X-Linked Severe Combined Immunodeficiency, Infantile Neutropenia, Graft Versus Host Disease (GvHD), and Bone Marrow Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bone Marrow TransplantDr. Chellapandian isExperienced. Learn about Bone Marrow Transplant.
- Chronic Granulomatous DiseaseDr. Chellapandian isExperienced. Learn about Chronic Granulomatous Disease.
- HistiocytosisDr. Chellapandian isExperienced. Learn about Histiocytosis.
- Infantile NeutropeniaDr. Chellapandian isExperienced. Learn about Infantile Neutropenia.
- Non-Langerhans-Cell HistiocytosisDr. Chellapandian isExperienced. Learn about Non-Langerhans-Cell Histiocytosis.
- ReticulohistiocytomaDr. Chellapandian isExperienced. Learn about Reticulohistiocytoma.